Goueslard K, et al. - Among young people with type 1 diabetes, researchers evaluated the supplementary morbidity and mortality risks conferred by the co-occurrence of schizophrenia. In this nationwide population-based study, people aged 15–35 years hospitalized in France for type 1 diabetes from 2009 to 2012 with or without schizophrenia were included. Data reported that patients suffering from the combination of type 1 diabetes and schizophrenia were at increased risk of hospitalization for acute diabetes complications and in addition suicide and hospital mortality. Specific care programs and close monitoring of mental, somatic, and social health were required for these individuals.